For the quarter ending 2025-09-30, TERN has $301,651K in assets. $17,585K in debts. $150,698K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 150,698 | 145,966 | ||
| Marketable securities | 144,937 | 169,479 | ||
| Prepaid expenses and other current assets | 4,660 | 3,507 | ||
| Total current assets | 300,295 | 318,952 | ||
| Property and equipment, net | 59 | 70 | ||
| Operating lease assets | 938 | 1,037 | ||
| Other assets | 359 | 356 | ||
| Total assets | 301,651 | 320,415 | ||
| Accounts payable | 2,946 | 2,849 | ||
| Accrued expenses and other current liabilities | 11,982 | 9,621 | ||
| Current portion of operating lease liabilities | 459 | 444 | ||
| Total current liabilities | 15,387 | 12,914 | ||
| Taxes payable, non-current | 1,628 | 1,583 | ||
| Operating lease liabilities, non-current | 570 | 689 | ||
| Total liabilities | 17,585 | 15,186 | ||
| Common stock, 0.0001 par value, 150,000,000 shares authorized at september 30, 2025 and december 31, 2024 87,511,470 and 87,126,583 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 9 | 9 | ||
| Additional paid-in capital | 778,065 | 774,724 | ||
| Accumulated other comprehensive income (loss) | 109 | -22 | ||
| Accumulated deficit | -494,117 | -469,482 | ||
| Total stockholders' equity | 284,066 | 305,229 | ||
| Total liabilities and stockholders' equity | 301,651 | 320,415 | ||
Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (TERN)